
Aziyo Biologics AZYO
Quarterly report 2025-Q3
added 11-12-2025
Aziyo Biologics Interest Expense 2011-2025 | AZYO
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Aziyo Biologics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.8 M | 5.12 M | 5.32 M | 5.63 M | 5.38 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.8 M | 5.12 M | 5.45 M |
Quarterly Interest Expense Aziyo Biologics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -1.44 M | -105 K | - | -257 K | 1.44 M | -758 K | 1.52 M | 1.43 M | - | 1.25 M | 1.2 M | 1.22 M | - | 1.33 M | 1.35 M | 1.36 M | - | 1.46 M | 1.41 M | 1.37 M | - | 1.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.52 M | -1.44 M | 884 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.79 | -1.81 % | $ 131 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 304.01 | -1.33 % | $ 8.58 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 45.24 | 0.24 % | $ 6.74 K | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 128.52 | 2.43 % | $ 224 B | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 92.05 | -0.56 % | $ 135 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 2.95 | 2.41 % | $ 110 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.63 | -2.37 % | $ 691 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 164.13 | -0.79 % | $ 12.3 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 96.6 | 0.38 % | $ 1.22 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 1.05 | -1.35 % | $ 108 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 12.47 | -1.89 % | $ 337 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 14.85 | 0.68 % | $ 97.3 M | ||
|
AxoGen
AXGN
|
-199 K | $ 29.92 | -1.55 % | $ 1.32 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.08 | -1.82 % | $ 1.24 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.94 | 1.92 % | $ 414 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 86.11 | -0.67 % | $ 11.7 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 13.58 | 1.19 % | $ 1.05 B | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 19.92 | -0.2 % | $ 2.85 B | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 62.59 | -0.25 % | $ 3.39 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.53 | 0.17 % | $ 133 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 3.23 | -5.11 % | $ 5.04 M | ||
|
Establishment Labs Holdings
ESTA
|
-15.3 M | $ 72.0 | -0.7 % | $ 2.03 B |